Daftar Login

MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated

MEREK : mbs303

MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated

mbs303MBS303 is a CD20×CD3 T-cell-engaging bispecific antibody that has a novel 2:1 (CD20:CD3) confuration to kill malnant B cells. This doseThe latest posts on #mbs303. Read what people are saying and join the conversation.

IDR 10.000
IDR 100.000 Disc -90%
Kuantitas